CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug keytruda takes on mysterious cancers of unknown origin
Disease control CompletedThis phase 2 trial is investigating whether the immunotherapy drug pembrolizumab (Keytruda) can help people with a rare and aggressive cancer called carcinoma of unknown primary (CUP), where doctors cannot find where the cancer started. Participants have not received prior treatm…
Matched conditions: CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New biomarker may predict which cancer drugs work best
Knowledge-focused CompletedThis completed study tested whether a new biomarker called 'mass response' can predict how well a cancer therapy will work. Researchers collected tumor cells from 72 patients with various cancers through fluid drainage or biopsies. The goal was to see if this biomarker could guid…
Matched conditions: CARCINOMA OF UNKNOWN PRIMARY
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC